Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04576078Phase 2Recruiting
Phase 2, randomised, double-blind trial in postoperative pain comparing NEFOPAM 60mg PO/ 8 hours with Placebo (2 arms). Primary endpoint: Total morphine consumption at 24 hours. Started Jun 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04576078.